Price $116.58 |
Market Cap
155.65B
|
Sector Health Care |
Div. Growth
7.70%
|
|
P/E
45.2
|
P/B
3.14
|
P/S
5.65
|
Dividend %
2.00%
|
|
P/CF
64.3
|
P/FCF
90.7
|
Op. Cash Flow
6M
|
FCF
1.2
|
|
Op. Margin
11.70%
|
Net Margin
12.70%
|
ROE
7.00%
|
ROI
6.70%
|
|
ROA
3.80%
|
EPS Growth
-24.20%
|
Current Ratio
2.1
|
Debt/Equity
43.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Community Health Systems Inc (CYH) | $10.11 | - | - | 884M | Strong Buy |
| Harrow Health Inc (HROW) | $8.63 | - | - | 159.6M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $4.39 | - | - | 166.4M | Strong Buy |
| China Pharma Holdings, Inc. (CPHI) | $0.68 | - | - | 19.8M | Strong Buy |
| STRATA Skin Sciences Inc (SSKN) | $1.91 | - | - | 50.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
